NYU Langone Health
New York, 10016, United States
NCT Number: NCT03723707
The purpose of this study is to develop and test a care quality improvement intervention featuring use of consensus decisional guidance for the medical management of diabetes (DM) in patients with Alzheimer's disease and related dementia (ADRD) in primary care, provider (PCP) workflow enhancements supported by a panel manager(PM) for workflow support, electronic health record (EHR) decision support and feedback, and PCP collaborative learning.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
New York, 10016, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Caregiver:
Exclusion criteria
Patient:
Caregiver:
(10 clinic sites and ~500 patients) which includes practice guidelines for clinicians, provider education, electronic health record support for quality DM-ADRD care, information about community/clinical resources, ongoing targeted provider feedback, and a panel manager (PM)
Will use current guidelines for primary care treatment with Diabetes and Dementia
Time frame: Up to Month 24
Percentage of patients with normal HbA1c (>=7 and <=8.5) at the end of the trial after completing the 24-month Follow-up and who had reported values in their electronic health record within 6 months of study completion.
NYU Langone Health
Other
Acronym: EQUIPED-ADRD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04975464
Alzheimer Disease, Arterial Occlusive Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT05704309
Alzheimer Disease, Arterial Occlusive Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT06203106
ALS, Adnexal Diseases
New York, United States
View Trial DetailsNCT02742597
Alzheimer Disease, Alzheimer's Disease
London, Ontario, Canada
View Trial Details